Investigational Drug Information for Ritanserin
✉ Email this page to a colleague
What is the development status for investigational drug Ritanserin?
Ritanserin is an investigational drug.
There have been 3 clinical trials for Ritanserin.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2003.
The most common disease conditions in clinical trials are Panic Disorder, Depressive Disorder, Major, and Cocaine-Related Disorders. The leading clinical trial sponsors are Beth Israel Medical Center, National Institute on Drug Abuse (NIDA), and University of Pennsylvania.
Summary for Ritanserin
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 2,032 |
WIPO Patent Applications | 853 |
Japanese Patent Applications | 305 |
Clinical Trial Progress | Phase 2 (2003-01-01) |
Vendors | 0 |
Recent Clinical Trials for Ritanserin
Title | Sponsor | Phase |
---|---|---|
Risperidone vs. Paroxetine for Panic Attacks | Beth Israel Medical Center | Phase 2 |
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks | Beth Israel Medical Center | N/A |
Ritanserin in Treatment of Cocaine Dependence - 1 | National Institute on Drug Abuse (NIDA) | Phase 2 |
Clinical Trial Summary for Ritanserin
Top disease conditions for Ritanserin
Top clinical trial sponsors for Ritanserin
US Patents for Ritanserin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |